Gautam Jayram

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Trends in Renal Surgery: Robotic Technology is Associated with Increased Use of Partial Nephrectomy

Hiten D. Patel, Jeffrey K. Mullins, Phillip M. Pierorazio et al. · The Journal of Urology · 2012 · 259 citations

Global Trends in Testicular Cancer Incidence and Mortality

A Rosen, Gautam Jayram, Michael W. Drazer et al. · European Urology · 2011 · 173 citations

Infertility, Urology, Urologic Cancer Epidemiology +10

The Impact of Mechanical Bowel Preparation on Postoperative Complications for Patients Undergoing Cystectomy and Urinary Diversion

Michael C. Large, Kyle J. Kiriluk, G. Joel DeCastro et al. · The Journal of Urology · 2012 · 88 citations

Comorbidities and causes of death in the management of localized <scp>T</scp>1a kidney cancer

Hiten D. Patel, Max Kates, Phillip M. Pierorazio et al. · International Journal of Urology · 2014 · 55 citations